BlackRock Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $131M | Sell |
356,866
-245,615
| -41% | -$90.2M | 0.13% | 160 |
|
|
2016
Q3 | $242M | Buy |
602,481
+183,538
| +44% | +$73.8M | 0.25% | 97 |
|
|
2016
Q2 | $146M | Buy |
418,943
+227,998
| +119% | +$79.6M | 0.15% | 152 |
|
|
2016
Q1 | $68.8M | Sell |
190,945
-71,521
| -27% | -$25.8M | 0.07% | 257 |
|
|
2015
Q4 | $142M | Buy |
262,466
+20,224
| +8% | +$11M | 0.15% | 149 |
|
|
2015
Q3 | $113M | Sell |
242,242
-17,697
| -7% | -$8.23M | 0.12% | 180 |
|
|
2015
Q2 | $133M | Sell |
259,939
-172,728
| -40% | -$88.1M | 0.14% | 160 |
|
|
2015
Q1 | $195M | Sell |
432,667
-120,098
| -22% | -$54.2M | 0.2% | 127 |
|
|
2014
Q4 | $227M | Sell |
552,765
-205,344
| -27% | -$84.2M | 0.23% | 112 |
|
|
2014
Q3 | $273M | Sell |
758,109
-177,228
| -19% | -$63.9M | 0.27% | 88 |
|
|
2014
Q2 | $264M | Buy |
935,337
+356,403
| +62% | +$101M | 0.25% | 100 |
|
|
2014
Q1 | $174M | Sell |
578,934
-104,139
| -15% | -$31.3M | 0.17% | 147 |
|
|
2013
Q4 | $188M | Buy |
683,073
+44,159
| +7% | +$12.2M | 0.18% | 141 |
|
|
2013
Q3 | $200M | Buy |
638,914
+311,756
| +95% | +$97.5M | 0.2% | 131 |
|
|
2013
Q2 | $73.6M | Buy |
+327,158
| New | +$73.6M | 0.08% | 250 |
|